Interview with John Norman, Country Manager, Nycomed South Africa
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
Address: 321 Main road, La Rocca,
Office Park, building D
Bryanston 2021,South Africa
Tel: 011 463 5733
Batswadi Pharmaceuticals (Pty) Ltd. operates as a clinical research company.
Batswadi was founded by CEO, Christopher Whitfield and Hennie Visser, Batswadi (meaning parent in Tswana) aims to increase Africa’s access to innovative products, diagnostics, devices and services.
Batswadi’s strategic partnerships with key stakeholders enable it to deliver economic benefits to its shareholders while simultaneously increasing African access to innovative products and technologies.
The management team has extensive experience in launching and marketing innovative products in the South African pharmaceutical market. Their experience in the evolution of the market provides deep understanding of critical developments expected into the future.
Batswadi specializes in clinical trials from phases II, III and IV.
The company focuses on four platforms: biotechnology, pharmaceuticals, diagnostics and clinical research. We further provide innovative medical companies with a presence in Africa, as well as the required infrastructure to launch their products on the continent.
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes in the market since…
South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the most exciting market he…
Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over the recent years? MC…
Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have been the first South African appointed…
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
Our international readers know about South Africa’s socio-economic relative achievements, considering the country joined the BRICS grouping last year and achieved the first Millennium Development Goal (MDG) that same year.…
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for us on the main…
The story of Novo Nordisk South Africa began in 1959 in Johannesburg. It was among the first affiliates outside of Denmark, with insulin and anti-infectives produced locally. To what extent…
You have worked at Roche for several years as Business unit Manager. Therefore you are familiar with the strategy of the company and the intricacies of the job. The new…
Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations as the General Manager of…
See our Cookie Privacy Policy Here
